This guy Joseph Rago, only 34 years old, is a Pulitzer Prize winning writer for the wall street journal who just happened to be looking into Veropharm a huge drug company that was sold to Abbott labs a few years ago in a very suspicious manner.
WTD has done excellent work on this and is all over it as are Jason Goodman, George Webb and many Freepers.
here's apost I made:
www.therussophile.org/wall-street-journal-reporter-asks-russia-for-clinton-information-turns-up-dead-2-days-later.html/
Wall Street Journal Reporter Asks Russia For ‘Clinton Information’ —-Turns Up DEAD 2 Days Later
This post was originally published on this site
View Comments
A Wall Street Journal Editor who was investigating how a Russian Pharmaceutical firm could have been purchased in 2014 by an American Pharmaceutical firm while Sanctions against Russia existed against such business transactions, has been found dead in his New York City apartment. The crux of the dead journalists investigation was how then-Secretary of State Hillary Clinton influenced the transaction to be finalized, but only AFTER her husband Bill was paid $500,000 for giving a speech in Moscow.
The Russia Consulate General’s office in New York City was contacted by Wall Street Journal reporter/editor Joseph Rago who requested a Thursday (20 July) in person interview with consular officials regarding an upcoming article he was preparing on Hillary Clinton and her links to Russia. Rago failed to attend the meeting and was later discovered dead in his apartment of as yet “unknown causes” just hours prior to this meeting occurring.
Joseph Rago was a Pulitzer Prize winning reporter whose expertise was in the health care field. His stated purpose for this meeting was his investigating Hillary Clinton’s links to the 2014 sale of Veropharm (one of Russia’s largest medical companies) to the American medical giant Abbott Laboratories.
Critical to note about Abbott Laboratories acquiring Veropharm, is that the deal was FINALIZED on December 12, 2014; 9 months AFTER Sanctions were imposed upon Russia. It may interest some to know that Russian sanctions could be “Waived” . . . . by the State Department, for instance!
This takeover of Veropharm was structured to evade the Obama regime sanctions against Russia, and was accomplished by a US shell company named Kew Garden Hills, LLC — registered in Delaware –and– Hillary Clinton’s home State of New York — acquiring approximately 98% of Veropharm shares—and then that shell company, Kew Garden Hills, LLC, being bought by Abbott Laboratories.
Interestingly, Kew Garden Hills, LLC, has no officer, directors, or even corporate information listed in the S&P Global Market Intelligence database; a strange fact for a firm involved in a multi-billion dollar US/foreign pharmaceutical acquisition. Here, check the S&P Global Market Intelligence data for yourself.
Handling this transaction, was the Russian investment bank Renaissance Capital — who are noted for their having paid former President Bill Clinton $500,000 for a speech he gave before their top executives in Moscow.
Rago told Russian consular officials that he had documents linking Hillary Clinton to both Abbott Laboratories and Kew Garden Hills, so it was believed by them that this was the line of inquiry he was going to pursue during his requested meeting — which never took place because Rago turned up dead.
The mysterious death of the 34-year-old Joseph Rago, follows by less than 2 weeks the “suicide” of another Hillary Clinton linked person named Renwick Haddow—a top former Haitian government official who ended up with a bullet in his head just a week prior to his testifying against Hillary Clinton in a Miami, Florida, courtroom.
These facts beg the question: Was Wall Street Journal Editor/Reporter Joseph Rago killed to prevent publication of his Hillary Clinton-Russia story? ............. So far there is no COD which is key to anything like the suspicious death of a Pulitzer Prize winning Wall Street Journal editorial writer.THis story is far from over.
Hope the Rago story isn’t dead as well. Seems to me that Abbott is at great risk for violating the sanctions and that the Board has an obligation to make sure that the deal which looks fishy at best is not in violation of the sanctions. A major shareholder might be persuaded to sue the Board and the CEO for placing Abbott in jeopardy. SEC? Wall Street Journal should be on this given it’s Rago who was much admired.